Disposable Gloves Market is projected to be about US$ 64.8 Mn by 2032 | FMI

According to the latest report by Future Market Insights on global Disposable Gloves market, the market is expected to register the growth of 8.5% CAGR through 2022 and beyond.

With the latest insights and statistics from the biggest pharmaceutical and healthcare device manufacturers across the globe, FMI presents an extensive analysis on Disposable Gloves market. FMI offers insights into the market data on over 5000+ drugs for more than 100 countries, which further aids the research on current and upcoming market scenario for the Disposable Gloves market. Our expert researchers and analysts for healthcare tracks the data of established players as well as new entrants in medical industry to provide an unbiased analysis for a sound and financial decision.

š‘®š’†š’•Ā š‘³š’‚š’•š’†š’”š’•Ā š‘ŗš’‚š’Žš’‘š’š’†Ā š‘Ŗš’š’‘š’š:@Ā https://www.futuremarketinsights.com/reports/sample/rep-gb-11231

Over the past decade, healthcare sector has been expanding remarkably, following the advent of artificial Intelligence and the Internet of Things integrated medical devices. Advancement in technology has created impressive scope within the medical sector for diagnostics and therapeutics.

The report offers extensive data sets validating key trends impacting growth in the Disposable Gloves market. It offers insights into strategies adopted by the key players rise and address the concerns that will challenge the growth of Disposable Gloves market. With our extensive research and information about the past, current and future market scenario, the Disposable Gloves market report will help and identify the concerns, for a smooth-sail of the small & medium as well as large enterprises.

Critical Questions Answered in the Report

  1. What are ongoing trends that will shape market growth curve for global Disposable Gloves market?
  2. What are the drivers and challenges affecting the Disposable Gloves market demand?
  3. What are the recent technological advancement in the Disposable Gloves market?
  4. What are key trends and opportunities that will prevail the revenue growth of Disposable Gloves market players?
  5. How will evolving regulatory policies impact the market growth?

š‘Øš’”š’ŒĀ š’‡š’“š’š’ŽĀ š’•š’‰š’†Ā š‘“š’‚š’“š’Œš’†š’•Ā š‘¹š’†š’”š’†š’‚š’“š’„š’‰Ā š‘¬š’™š’‘š’†š’“š’•Ā @Ā https://www.futuremarketinsights.com/ask-question/rep-gb-11231

Key Players:

  • Ansell Ltd
  • Top Glove Corporation Bhd
  • Hartalega Holdings Berhad
  • Supermax Corporation Berhad
  • Kossan Rubber Industries Bhd
  • Ammex Corporation
  • Kimberly-Clark Corporation
  • Sempermed USA, Inc.
  • MCR Safety
  • Kossan Rubber Industries BHD
  • Kimberly-Clark Corporation
  • Sempermed USA Inc.
  • Halyard Health Inc.,
  • Corporativo DL S.A. de C.V.
  • Medline Industries Inc.
  • Mƶlnlycke Health Care AB
  • Atlantic Safety Products Inc
  • Adenna LLC.

Key Segments Covered in the Disposable Gloves Industry Survey

By Product:

  • Natural Rubber Gloves
  • Nitrile Gloves
  • Vinyal gloves
  • Neoprene
  • Polythylene
  • Others

By Form:

  • Powdered
  • Non Powdered

By Application:

  • Medical
  • Examination
  • Surgical
  • Non-medical
  • Food Processing
  • Foodservice
  • Industrial

By End User:

  • Medical
  • Chemical
  • Automotive
  • Oil & Gas
  • Others

š‘©š’–š’šĀ š’•š’‰š’Šš’”Ā š’“š’†š’‘š’š’“š’•Ā @Ā https://www.futuremarketinsights.com/checkout/11231

Why Future Market Insights?

  • Comprehensive analysis on evolving purchase pattern across different geographies
  • Detailed insights of market segments and sub-segments for historical as well as forecast period
  • A competitive analysis ofĀ  prominent players and emerging players in the Disposable Gloves market
  • Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years
  • Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
LinkedIn|Ā Twitter|Ā Blogs
For Sales Enquiries:Ā sales@futuremarketinsights.com
Website:Ā https://www.futuremarketinsights.com

Breath Analyzers Market to reach a valuation of US$ 3.40 Billion by 2032 | FMI

[250 Pages Report] The GlobalĀ Breath Analyzers marketĀ study provides critical information related to the global, regional and top players including Breath Analyzers market share analysis, winning strategies, recent developments, and financial planning. Besides providing information regarding the key players in the Breath Analyzers market, the study also recalibrates, the impact of macroeconomic and microeconomic factors that has the potential to impact the growth of the Breath Analyzers market.

Over the past decade, healthcare sector has been expanding remarkably, following the advent of artificial Intelligence and the Internet of Things integrated medical devices. Advancement in technology has created impressive scope within the medical sector for diagnostics and therapeutics.

Request Sample @Ā https://www.futuremarketinsights.com/reports/sample/rep-gb-1066

Understanding the Impact of Covid-19 on Healthcare Industry

With the pandemic plaguing maximum countries across the globe, healthcare industry is witnessing its fair share of ā€˜ups and downsā€™. The COVID-19 has placed an enormous strain on the healthcare sectorā€™s workforce, facilities and infrastructure. Despite the endless pressure, healthcare sector is growing at a moderate pace due to the improvement in infrastructure and advancement in technology, healthcare sector is delivering a healthy performance.

The FMIā€™s latest report on the Breath Analyzers market gives a detailed analysis on the impact of COVID-19 with an incisive coverage on the innovative strategies adopted by the market players to survive the challenges due to pandemic.

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint.

Any Queries About Report, Contact UsĀ @Ā https://www.futuremarketinsights.com/askus/rep-gb-1066

Breath Analyzers Market: Segmentation

Based on technology, the global breath analyzers market is segmented into the following:

  • Semiconductor Oxide technology
  • Fuel cell technology
  • Infrared absorption technology

Based on application, the global breath analyzers market is segmented into the following:

  • Alcohol detection
  • Drug abuse detection
  • Asthma detection
  • pylori infection detection
  • Tuberculosis detection
  • Others

Based on end users, the global breath analyzers market is segmented into following:

  • Law Enforcement Agencies
  • Enterprises
  • Individuals

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil)
  • Western Europe (Germany, Italy, U.K, Spain, France, Rest of Western Europe)
  • Eastern Europe (Russia)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC, S. Africa)

Comprehensive analysis of the regional markets offers exclusive insights on the market performance across geographies along with relevant graphs, figures, and list of tables.

Request For Table of ContentĀ @Ā https://www.futuremarketinsights.com/toc/rep-gb-1066

Competitive Analysis

By Prominent Market Players

DrƤgerwerk AG & Co. KGaA, EnviteC-Wismar GmbH, Lifeloc Technologies, BACtrack, Inc., Quest Products, Inc., Akers Biosciences, Inc., Intoximeter, Inc., AK GlobalTech Corporation etc.

With an extensive SWOT analysis, the FMIā€™s study presents the strengths, weaknesses, growth prospects and challenges of each player. The report also includes important data including the sales strategy, pricing strategy, and marketing strategy adopted by these players in the Breath Analyzers market

Reasons to Buy the report

  • We provide authentic and detailed an analysis on various market trends to enable businesses to make informed and beneficial decisions to attain competitive edge over key players.
  • Our analysts provide detailed market segmentation along with meaningful insights and extensive reports that other companies fail to include.
  • The report includes accurate analysis of the market and the current developing trends affecting the growth. FMI speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, industry experts. This ensures that the data collected is from highly reliable sources.

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
LinkedIn|Ā Twitter|Ā Blogs
For Sales Enquiries:Ā sales@futuremarketinsights.com
Website:Ā https://www.futuremarketinsights.com

Dental Chairs Market is projected to reach US$ 851 Million by 2032 | FMI

 

The globalĀ dental chair marketĀ is valued at US$ 516.5 Mn in 2022 and is expected to reach US$ 851 Mn by 2032, expanding at a CAGR of 5.1% between 2022 and 2032. According to Future Market Insights, a market research and competitive intelligence provider, global dental chair sales has increased at a CAGR of 4.9% over the last half-decade.

The improvement of technology has led in an increase in the adoption rate of dental chairs. The modern dental chair has unrivaled characteristics that assist both the dental expert and the patient in operating and remaining calm during the operation. Recently, dual-position touchpad controls have been installed on both sides of the top backrest for convenience of access. There is an option to add a unit-mounted touchpad, wireless foot control, and distant wireless touchpad to the twin touchpad controls. Advanced features are expected to drive further demand for dental chairs.

Request Sample @Ā https://www.futuremarketinsights.com/reports/sample/rep-gb-15083

Market growth is expected to be boosted by oral health diseases. The oral illness affects roughly 3.5 Bn people worldwide, according to the Global Burden of Disease Study, with caries of permanent teeth being the most frequent. Caries of permanent teeth affect an estimated 2.3 Bn individuals worldwide, whereas caries of primary teeth affect more than 530 Mn children. The rising frequency of oral problems is expected to raise the demand for dental examination and treatment chairs.

Key Takeaways from Market Study

Global dental chairs market is expected to witness an absolute dollar opportunity of US$ 334.6 Mn between 2022 and 2032 Among key types, powered dental chairs account for the largest share and revenue through this segment is projected to grow at a CAGR of 5.8% during 2022 ā€“ 2032 Among product type, revenue through ceiling mounted design of dental chairs is projected to witness a CAGR growth of 5.8% during the forecast period North America led the dental chairs sales worldwide with a share of over 35% in 2021

Ask An Analyst @Ā https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-15083

Winning Strategy

Increased frequency of dental infections and periodontal diseases, surged need for dental care facilities, and dental surgical treatments, as well as technological improvements, are driving the growth of the dental chair market. However, the industry is expected to be hampered by high prices associated with modern dental chairs and worries about dental insurance payment. Emerging economies, on the other hand, are likely to provide considerable profit prospects for market participants due to developments in the healthcare industry.

Competitive Environment

The global dental chairs market is fragmented and tremendously competitive for major competitors. To retain their positions, key market actors are emphasizing the quality of their products while releasing new things more often.

Existing technology advancements, product development and launches, and public awareness campaigns all contribute to a more competitive climate. Some of the most well-known players in the global dental Chairs industry are as follows: Austin Dental Equipment Company (A-Dec, Inc.), Midmar, Craftsmaster Contour Equipment, Inc., XO CARE A/S, and Sirona are among the companies involved.

ā€¢ In June 2019, A-dec, announced the launch of the A-dec 500 dental chair brand. The companyā€™s customer base is expected to increase as a result of the launch.

Request Brochure @Ā https://www.futuremarketinsights.com/reports/brochure/rep-gb-15083

More Insights Available

Future Market Insights, in its new offering, presents an unbiased analysis of the Dental Chairs Market, presenting historical market data (2017-2021) and forecast statistics for the period of 2022-2032.

The study reveals extensive growth in Dental Chairs Market in terms of Type (Powered Dental Chairs, Non-powered Dental Chairs), by Product Type (Ceiling Mounted Design, Mobile Independent Design, Dental Chair Mounted Design), by Application (Examination, Surgery, Orthodontics, Other Applications) across five regions (North America, Latin America, Europe, Asia Pacific and Middle East & Africa).

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
LinkedIn|Ā Twitter|Ā Blogs
For Sales Enquiries:Ā sales@futuremarketinsights.com
Website:Ā https://www.futuremarketinsights.com

Proteinase K Market is expected to rise at a yearly growth rate of 7.0% Y-o-Y to $159.22 million in 2032 | FMI

Proteinase K is a million dollar market accounting for a small portion in reagents and enzymes. Proteinase K is mainly used in contract research organisations, biotechnology companies, academic institutes, and diagnostics laboratories. In terms of revenue, the globalĀ Proteinase K marketĀ is expected to reach US$ 33.4 Mn by the end of 2026, witnessing a CAGR of 6.1%.

A plethora of factors are expected to impact the growth of the global Proteinase K market. A significant rise in research and development activities, lesser production costs, broader application of Proteinase K and good product stability and specificity of Proteinase K will give a massive push to the revenue growth of theĀ globalĀ Proteinase K marketĀ by the end of the forecast period. A steady rise of chronic diseases and better government backed investment channels to fund advanced research and development are expected to boost the expansion of the global Proteinase K market over the period of assessment. An increasing number of research activities, soaring expenditure on personal healthcare and increasing adoption of gene therapy has been significantly high in the U.S. market in the recent years, making North America the most lucrative regional market for Proteinase K.

Get Sample Report@ Ā https://www.futuremarketinsights.com/reports/sample/rep-gb-2399

Global Proteinase K Market: Segmental Forecast

  • By form, the lyophilized powder form segment is anticipated to account for higher revenue share in the global Proteinase K as compared to the liquid form segment. Lyophilized powder from segment is expected to reach a market value of US$ 19.2 Mn by 2026, reflecting a CAGR of 6.3% over the forecast period. The growth in lyophilized powder form can be attributed to the increasing advantages of powder form over liquid form in case of storage and preservation of samples.
  • By application, purification of DNA & RNA segment will account for the highest revenue share in the global Proteinase K market as compared to other applications of Proteinase K. Purification of DNA & RNA segment is expected to reach a value of US$ 19.2 Mn by 2026, reflecting a CAGR of 6.5% over the forecast period.
  • By end user, the biotechnology companies segment is expected to project higher demand for Proteinase K as compared to other end user segments such as academic institutes and diagnostics laboratories. The strong growth in biotechnology companies can be attributed to an increasing use of Proteinase K in research and development and new drug discovery. The cost effectiveness of Proteinase K over other reagents is the key factor responsible for its increasing use in biotechnology companies. The biotechnology companies segment is expected to register the highest CAGR of 6.7% over the forecast period.

Global Proteinase K Market: Regional Market Projections

Demand for research in academics and funding facilities provided by the U.S government to support gene therapy and other activities for drug development is anticipated to boost the North America Proteinase K market. Followed by North America, Western Europe and APEJ are the most lucrative regions in the global Proteinase K market and are anticipated to grow by 5.7% and 6.1% respectively over the forecast period. Increasing demand for drug development, rising hereditary diseases due to changing lifestyles and growing disposable income are some of the factors expected to contribute to the growth of the global Proteinase K market.

Ask from Market Research Expert ā€“Ā https://www.futuremarketinsights.com/ask-question/rep-gb-2399

Global Proteinase K Market: Vendor Insights

Top companies profiled in the global Proteinase K market report include Thermo Fisher Scientific Inc., Merck KGaA, Qiagen N.V., Worthington Biochemical Corporation, Sisco Research Laboratories Pvt. Ltd, Promega Corporation, Bioline and F. Hoffmann-La Roche AG among others. Leading market players are adopting different strategies such as product launches and acquisitions to maintain their market share. For instance, in November 2015, Merck KGaA acquired Sigma-Aldrich to strengthen and expand its consumable and reagent portfolio.

Market SegmentationĀ Form

  • Lyophilized Powder Form
  • Liquid Form

Application

  • Isolation and purification of genomic DNA & RNA
  • In Situ Hybridization
  • Mitochondria isolation
  • Enzyme Removal

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries:Ā sales@futuremarketinsights.com
Website:Ā https://www.futuremarketinsights.com
LinkedIn|Ā Twitter|Ā Blogs

Ophthalmic Lasers Market is projected to increase from a valuation of US$ 884.3 Mn in 2022 to US$ 1.3 Bn by 2030

[294 Pages Report] Technological advancements have deeply penetrated every facet of the healthcare industry, and theĀ ophthalmic lasers marketĀ is no exception. Over the years, ophthalmic disorders such as diabetic retinopathy, refractive errors, glaucoma, cataract and age related macular degeneration (AMD) have surged exponentially. This has accelerated demand for advanced surgical procedures.

The introduction of ophthalmic laser surgery has revolutionized ophthalmic care in unprecedented ways. Majority of these technologies are being deployed in cataract surgeries, attributed to the disorderā€™s widespread prevalence across all continents. Advancements such femtosecond laser surgeries have proven highly instrumental in streamlining ophthalmic procedures, offering lightning speed detection of faulty tissues.

Such reduced detection and treatment timeframes act as major growth catalysts for the global ophthalmic lasers market, which is anticipated toĀ reach a value of US$ 1.3 Bn by 2030.

Get Sample Report@ Ā https://www.futuremarketinsights.com/reports/sample/rep-gb-1529

Market Outlook:

Data Points Market Insights
market Value 2021 USD 838.4 Mn
market Value 2022 USD 884.3 Mn
market Value 2030 USD 1.3 Bn
CAGR 2022-2030 5.4%
Share of Top 5 Countries 60.4%
Key Players The key players in ophthalmic lasers market are Abbott Medical Optics, Inc., Alcon Inc. (Novartis AG), Bausch & Lomb Incorporated, LENSAR, LLC, NIDEK CO., LTD, iVIS Technologies, ZEISS International, Ziemer Ophthalmic Systems AG, and SCHWIND eye-tech-solutions GmbH & Co. KG.

Ophthalmic Lasers Market- Key Highlights

  • Ophthalmic lasers market shall expand steadily at aĀ CAGR of 5.4%Ā from 2022-2030
  • Cataract surgeries shall account for the majority share of the global ophthalmic lasers market
  • Femtosecond laser surgery to hold maximum sway throughout the forecast period
  • North America shall retain market hegemony, owing to increasing regulatory approvals for laser surgeries by authorities
  • Asia & Europe to contribute nearly identical revenue shares due to rise in surgeries amidst their geriatric population

Ask from Market Research Expert ā€“Ā https://www.futuremarketinsights.com/ask-question/rep-gb-1529

COVID-19 Impact Analysis

The novel coronavirus pandemic will have a significantly high impact on the ophthalmic lasers market. As lockdowns and curbs continue to remain enforced, the number of footfalls across ophthalmology clinics and hospitals have declined considerably. Patient care has diminished by nearly 60%, with only emergency surgeries being permitted.

With in-patient visits becoming next to impossible, ophthalmologists are resorting to telemedicine with regards to consultation and advice to patients. A slump is anticipated in refractive and premium lens surgeries across developing economies in the long-run, attributed to cash crunches experienced by individual households due to the prolonged lockdowns.

At the same time, several countries are enforcing strict social distancing protocols and hygiene practices, keeping demand for ophthalmic laser surgeries sustained. For instance, ophthalmologists in Germany have made it a protocol to test patients requiring intravitreal injections and other procedures for COVID-19. If positive, they are redirected to emergency departments, reducing chances of infection.

ā€œVendors in the ophthalmic lasers landscape are striving to introduce novel product lines, equipped with multi-frequency selection modes to reduce exposure to intense laser bursts, preventing healthy tissue damage,ā€ infers the FMI analyst.

Competition Dashboard

Prominent vendors in the ophthalmic lasers market include are ZEISS International, Nidek Inc., Bausch & Lomb Inc., Abbot Laboratories Inc., SCHWIND Eye-Tech Solutions, Ziemer Ophthalmic Systems AG, Novartis AG (Alcon), LENSAR LLC., iVIS Technologies and NKT Photonics A/S. New product launches and collaborations have helped these players acquire firm footing.

In 2018, ZEISS International rolled out its VISUFIT 1000 digital 3D centration data determination and consultation platform, offering a three-dimensional facial reconstruction which enables ophthalmologists perform precise centration processes on patients.

In July 2022, SCHWIND Eye-Tech acquired CE approval for its SCHWIND ATOS femtosecond laser, permitting eye surgeons to incorporate the technology in their SmartSight refractive surgery procedures.

More Insights on the Ophthalmic Lasers Market

A recent market study published by FMI on the ophthalmic lasers market includes the global industry analysis of 2014-2021Ā & opportunity assessment for 2022-2030, and delivers a comprehensive assessment of the most important market dynamics. The report provides a balanced, unbiased analysis of the overall market scenario based on product type (excimer lasers and femtosecond lasers), application (refractive surgery, cataract surgery, capsulotomy, trabeculoplasty and diagnostics), end-user (hospitals, ophthalmology clinics and ambulatory surgical centers) and region (North America, Latin America, Europe, East Asia, South Asia, Oceania and Middle East & Africa).

For in-depth insights, Download a PDF Brochure ā€“Ā https://www.futuremarketinsights.com/reports/brochure/rep-gb-1529

Ophthalmic lasers market by Category

By Product :

  • Excimer Lasers
  • Femtosecond Laser

By Application :

  • Refractive Surgery
  • Cataract Surgery
  • Posterior Capsulotomy
  • Trabeculoplasty
  • Diagnostic

By End user :

  • Hospital
    • 500 Bedded+
    • 250-499 Bedded
    • Less than 250
  • Ambulatory Surgical Centers
  • Ophthalmology Clinics

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries:Ā sales@futuremarketinsights.com
Website:Ā https://www.futuremarketinsights.com
LinkedIn|Ā Twitter|Ā Blogs

Allergy Diagnostics Market is expected to grow at an 11.3% CAGR from 2022 to 2032 | FMI

[170 Pages Report] According to ESOMAR-certified Future Market Insightsā€™ (FMIā€™s) research report, the demand for allergy diagnostics has been increasing significantly due to rising incidence of allergic asthma and food allergies across the globe. As per the study, the globalĀ allergy diagnostics marketĀ is anticipated to grow at around 11.6% CAGR throughout the forecast period from 2021 to 2031.

According to the report, growing incidence of drug allergies especially from penicillin and morphine has fueled the demand for allergy diagnostics across the globe.

The report also states that increasing air pollution and lack of awareness regarding food and drug allergy in emerging and poor countries are encouraging market players towards developing cost effective allergy diagnostics kits.

According to a report published by the World Health Organization, globally around 262 million people are impacted by asthma out of which 461,000 die from asthma.

Rising demand for effective treatment and addressing causes of asthma will aid the overall expansion of the allergy diagnostics market.

Allergy diagnostics market experienced sluggish growth during the COVID-19 pandemic. This is because the pandemic led to suspension of immunological care and diverted the healthcare professional towards treating COVID patients.

In case of patients with severe asthma or other allergic reaction, virtual care and limited visiting methods were employed to restrict the human contact and stop the virus transmission.

Introduction of cost effective at-home food sensitivity and allergy diagnostic will boost the market growth in upcoming years. Such applications will reduce the burden on hospital and laboratories culminating to reduced allergy diagnostic and medical cost.

In the future, the market is anticipated to grow significantly, as majority of diagnostic laboratories and hospitals are inclining towards automated allergy diagnostics for its high effectiveness. Canada and U.S are likely to yield highly opportunistic prospects, contributing towards the overall expansion of the market.

To remain ahead of your competitors, request for a sample ā€“Ā https://www.futuremarketinsights.com/reports/sample/rep-gb-4959

ā€œSurge in food allergies cases along with increasing incidence of asthma in children will catapult the demand of allergy diagnostics during the forecast period,ā€ says the FMI analyst.

Competitive Landscape

Allergy diagnostics market is highly competitive market owing to presence of global market players. Market players are employing multiple marketing techniques to expand their global outreach.

Allergy diagnostics market players are focusing towards employing organic and inorganic strategies to expand their global foothold.

Inorganic strategies include strategic merger and acquisition and forming an alliance with regional distributors to strengthen their supply chain channels.

They are also emphasizing towards faster product approvals, product development and patenting.

Prominent players operating in the allergy diagnostics market are:

  • Hitachi Chemical Co. Ltd
  • Thermo Fisher Scientific Inc.
  • Siemens Healthineers
  • Danaher Corporation
  • HOB Biotech Group Co
  • bioMĆ©rieux
  • Hycor Biomedical Inc.
  • Stallergenes Greer
  • R-Biopharm AG
  • Lincoln Diagnostics Inc.

Ask from Market Research Expert ā€“Ā https://www.futuremarketinsights.com/ask-question/rep-gb-4959

Key Takeaways from FMIā€™s Allergy Diagnostics Market Study

  • The U.S is expected to dominate allergy diagnostics market on the back of rising incidence of skin allergies especially eczema and skin inflammation along with high rate of allergic rhinitis (hay fever) in black American population.
  • Presence of advance healthcare infrastructure, favorable government and insurance policies, and increased per capita income are key allergy diagnostics market drivers in Canada.
  • The U.K. will offer lucrative opportunities owing to increasing awareness regarding asthma and other allergic reactions like atopic eczema and hay fever. High prevalence of allergies will fuel the demand of allergy diagnostics in the country.
  • Increasing per capita income and increasing government and private funding towards spreading asthma awareness will boost the allergy diagnostics market sales in China.
  • India has low per capita income and presence of sub-par healthcare system. High prevalence of myths and stigmatic beliefs regarding asthma is one of the main factors limiting the market growth.

More Insights on the Global Allergy Diagnostics Market

In its latest report, FMI offers an unbiased analysis of the global allergy diagnostics market, providing historical data for the period of 2017-2022 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of product type (fungal allergy diagnostic and neutral lactase enzymes), by allergen type (inhaled allergens, food allergens, and drug allergens), test type (in-vivoĀ allergy tests and in-vitro allergy tests), and end user (diagnostic laboratories, hospitals, and academic research institutes) across North America, Latin America, Europe, East Asia, South Asia, and Middle East and Africa.

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries:Ā sales@futuremarketinsights.com
Browse All Reports :Ā https://www.futuremarketinsights.com/reports
LinkedIn|Ā Twitter|Ā Blogs

Americas COVID-19 Testing Market is expected to surpass US$ 7,264.4 Mn by 2031 | FMI

[200 Pages Report] The market is set to expand due to frequent mutations in the virus that may lead to further outbreaks. Leading organizations within the market are set to focus on research and development to offer an early and precise diagnosis of the COVID-19, besides offering effective patient care.

Some of the leading players in theĀ Americas COVID-19 testing marketĀ include but are not limited to Sky Medical Supplies & Equipment LLC., Sugentech, Inc., Novacyt Group, Aurora Instruments Ltd., PRIMA Lab SA, SD Biosensor, INC., Gold Standard Diagnostics, Eurofins Technologies, Biomerieux SA, and Danaher.

According to Future Market Insights (FMI), the demand for COVID-19 testing is expected to reach a valuation ofĀ US$ 4,507.8 MnĀ in the Americas by the end of 2021. The pandemic is spreading on a global scale at a very high pace. It can cause various health concerns including cardiovascular diseases, kidney failure, and more.

To overcome the problems related to COVID-19, it is important to diagnose the ailment at an early stage of infection. According to the World Health Organization (WHO), more than 180 million positive cases ofĀ COVID-19 were diagnosedĀ till June 2021. The rate of positive cases can be controlled with early diagnosis and treatment.

SARS-CoV-2 antigenĀ rapid test kitsĀ are the most common type of test that accounted for value USD 2,903.0 Mn in 2020. It is widely accepted due to convenience, ease and rapid nature in the diagnosis process.

The demand for point of care testing is increasing due to advantages such as lower time requirements, at home services, and cost effectiveness. These factors are going to bolster the demand for point of care testing during the forecast period. For instance, on 28 July 2020, Roche announced the launch of the SARS-CoV-2 Rapid Antibody Test in collaboration with SD Biosensor Inc.

With the launch of vaccines and development of mass vaccination programs by governments, the number of COVID-19 cases is expected to drop by the end of 2021, however, it is expected that testing will continue even as lockdown in many countries will be lifted. Key players are focused on strengthening their mergers and acquisitions with new discoveries of technologies.

To remain ahead of your competitors, request for a sample ā€“Ā https://www.futuremarketinsights.com/reports/sample/rep-gb-13636

Key Takeaways from COVID-19 Testing Services Market Study

  • SARS-CoV-2 antigen rapid test kits are expected to account for over 67% theĀ Americas COVID-19 testing marketĀ share by 2031, owing to higher efficacy in diagnostics.
  • Hospital pharmacies accounted for more than 32% of the market share in 2021. The soaring influx of patients for treatment and intensive care support has driven growth.
  • Canada will reflect relatively steady growth with a 4.8% CAGR, driven by the matured, government funded healthcare system.
  • The U.S. will reflect fast growth at a CAGR around 5.7% through 2021-2031. U.S. holds the lead owing to, high healthcare expenditure, and the presence of leading players.
  • Brazil is the leading country in Latin America, estimated to account for about 54% of the regional share in 2021, supported by easier access to required technologies.

ā€œThe shift in focus from testing to vaccination is expected to hamper market growth in the near future. However, the focus on testing for international travel, frequent testing of medical staff and testing for patients with flu like symptoms are expected to continue aiding market growth,ā€Ā says the Future Market Insight analyst.

Want More Insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global COVID-19 testing market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on the COVID-19 testing treatment market on basis of the test type in detail, cover every aspect of the market such as Test type, sample type, distribution channel across North America and Latin America region.

Americas COVID-19 testing Market by CategoryTest Type:

  • SARS-CoV-2 IgM/IgG Antibody Rapid Test Kits
  • SARS-CoV-2 Antigen Rapid Test Kits
  • Multiplex Real-Time RT-PCR Assay Kits

Ask from Market Research Expert ā€“Ā https://www.futuremarketinsights.com/ask-question/rep-gb-13636

Sample Type:

  • Blood
  • Nasopharyngeal Swabs

Distribution Channel:

  • Hospital Pharmacies
  • Diagnostic Laboratories
  • Retail Pharmacies
  • Drug Store
  • Online Sales Channels

Region:

  • North America
  • Latin America

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries:Ā sales@futuremarketinsights.com
Browse All Reports :Ā https://www.futuremarketinsights.com/reports
LinkedIn|Ā Twitter|Ā Blogs

Actinic Keratosis Treatment Market is expected to reach US$ 8.0 Bn by 2028 | FMI

[275 Pages Report] Global demand for actinic keratosis treatment, majorly driven by that in the U.S. and European countries, continues to grow at a strong rate. Poised for revenues of over US$ 4 Bn by the end of 2019, the globalĀ actinic keratosis treatment marketĀ will exhibit an impressive CAGR of 7% during the forecast period (2019 ā€“ 2029).

The understanding about the nature of actinic keratosis and the potential risk of this condition progressing to squamous cell carcinoma (SCC) is improving, among patients as well as healthcare providers. Especially among the elderly, actinic keratosis remains one of the most commonly diagnosed dermatological condition that creates a continued need for efficacious treatments.

Who Is Winning?

The actinic keratosis treatment market report tracks the key market players, which includes GlaxoSmithKline Plc. Nestle SA, Novartis AG, Sun Pharmaceutical Ltd., Leo Pharma Inc. etc. Leading manufacturers in the actinic keratosis treatment market are focusing on acquisitions to enhance their product portfolio. For instance, in November 2015, Leo Pharma A/S completed the acquisition of dermatology business of Astellas Pharma. With this acquisition, the company expanded its dermatology product portfolio segment. Companies are also focusing on segment leadership. In February 2016, Cipher Pharmaceuticals Inc. launched Actikerall for the topical treatment of slightly palpable and/or moderately thick hyperkeratotic actinic keratosis to mark their leadership in topical product segment.

Combination therapies such as topical fluorouracil cryotherapy, PDT and imiquimod therapy, chemical peels, and 5-FU are generally the most prescribed therapies for actinic keratosis. Convenient administration, lower potential for irritation, and systemic absorption continue to underpin their high adoption rate. Development of drugs with increased efficacy and decreased side effects that can be used as combination therapy for actinic keratosis treatment is currently the focal point of global market leaders. Biofrontera AG commercially launched its product Ameluz (2016), used in combination with PDT for actinic keratosis treatment.

To remain ahead of your competitors, request for a sample ā€“Ā https://www.futuremarketinsights.com/reports/sample/rep-gb-3233

Development of minimally invasive drug-device combination therapies and fast track regulatory approval for pipeline drugs will be offering a completely new set of treatment options for actinic keratosis in the near future.

Key Takeaways ā€“ Actinic Keratosis Treatment Market Study

  • Growing use of topical products as the first-line preference for actinic keratosis treatment is offering huge opportunities to market players to develop and launch new topical products for actinic keratosis treatment.
  • Increasing collaboration activities by key market players of the actinic keratosis treatment market with other companies to broaden their products portfolio is anticipated to propel the actinic keratosis treatment market growth.
    • For instance, in March 2017, Galderma SA (Nestle Skin Health Company) collaborated with Colorescience, to enhance its product portfolio for aesthetic treatment.
  • Increasing product approvals of actinic keratosis treatment by regulatory bodies is expected to fuel the actinic keratosis treatment market growth.
    • For instance, in March 2018, combination of Ameluz and daylight photodynamic therapy (PDT) by Biofrontera AG got approval from the European Union.
  • The U.S. and Australia marking rise in incidence and prevalence of actinic keratosis will remain highly prominent markets for actinic keratosis treatment providers.

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on actinic keratosis treatment market in its latest study, presenting historical demand assessment from 2014 ā€“ 2018 and projections from 2019 ā€“ 2029 on the basis of treatment category (topical treatment, procedural modality, photodynamic therapy and others), disease type (clinical AK and subclinical AK)and end-user (hospitals, laser therapy centers, private dermatology clinics, spas and rejuvenation centers, cancer treatment centers, homecare) in seven key regions.

Ask from Market Research Expert ā€“Ā https://www.futuremarketinsights.com/ask-question/rep-gb-3233

Actinic Keratosis Treatment Market By Category

By Treatment Type:

  • Topical Treatment
    • 5-fluorouracil Cream
    • Diclofenac Gel
    • Imiquimod Cream
    • Ingenol mebutate Gel
  • Procedural Modality
    • Chemical Peels
    • Cryotherapy
  • Photodynamic Therapy
  • Others

By Disease Type:

  • Clinical AK
  • Subclinical AK

By End User:

  • Hospitals
  • Private Dermatology Clinics
  • Laser Therapy Centers
  • Cancer Treatment Centers
  • Spas and Rejuvenation Centers
  • Homecare

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries:Ā sales@futuremarketinsights.com
Browse All Reports :Ā https://www.futuremarketinsights.com/reports
LinkedIn|Ā Twitter|Ā Blogs

Ultrasound Systems Market is projected to reach USD 13.2 Bn by 2028 | Get Insights FMI

Digitization in the healthcare sector has revamped the ultrasound systems market. The advancements in different spheres of the industry has benefited not just the patients but the market too, as the demand for medical examination has surged over the past decade. A new market research report by Future Market Insights, revolves around an in-depth and an all-inclusive analysis of GlobalĀ Ultrasound Systems Market, reveals a strong growth of the market due to upgraded services provided to the patients and also the easier approach to the internal body examination witnessed with the usage of ultrasound systems.

According to the outcomes of global forecast mentioned in the report titled ā€˜Ultrasound SystemsĀ Market ā€“Ā Global Industry Analysis 2012 ā€“ 2021 and Opportunity Assessment 2022 ā€“ 2028ā€™,Ā the global ultrasound systems market is expected to reach a market value of over US$ 13.2Ā Bn by the end of 2028, growing at an impressive CAGR of 5.5% during the forecast period.

To remain ahead of your competitors, request for a sample ā€“Ā https://www.futuremarketinsights.com/reports/sample/rep-gb-6695

Hospitals to hold largest share in Ultrasound Systems Market with highest demand for application in Radiology

Hospitals shift toward more value-oriented products, they need to operate more efficiently and productively. Similarly, a quality shift has occurred with patients, who more proactively involved in their care. Trends from the shift to value-based care include data integration and population health management. An influx of data combined with advancements in imaging helps leverage these data to not only bring further value but also apply it to broader populations. Along with the clearer and high definition pictures that are a part of ultrasound systems, there has also been an introduction to the portable machines. These are the more handy and easy to move form of ultrasound systems that have come into existence not long ago. Although the developed nations are already familiar with the technology, the market may find a higher prospects of growth in the developing regions. The market analysis has shown that hospitals hold the highest market share in the Global Ultrasound Systems Market, however diagnostics imaging and surgical centers are expected to raise a higher demand for the systems in the coming years. In terms of application the market is also dominated by Radiology as the key application area for ultrasound systems and is expected to continue growing further at a CAGR of 6.3% during the forecast period, as analyzed by FMI.

Favourable Government Policies to Benefit Start-up Companies and Independent diagnostic centers

As a move to encourage start-up companies, government of various regions like Asia Pacific and MEA have bolstered the initiatives to support the new start-ups who are entering the healthcare and medical device industry. It includes exemption of taxes for the first three years, subsidizing patent protection cost etc. The move is intended to boost the overall market for medical devices. Specifically the medical imaging market has also taken an independent position in the global market. With the betterment in services and advanced facilities related to ultrasound or any other imaging techniques, the global market is expected to witness a higher volume of independent imaging centers. The companies have also independently introduced handy and user-friendly devices in the market. GE, Philips, Samsung, Fukuda, Mindray, Hitachi, Toshiba, and Siemens, all these companies offer their own particular models.

The coming years will showcase more advanced ultrasound systems, which will provide an image clearer than 3D or 4D pictures.

Ask from Market Research Expert ā€“Ā https://www.futuremarketinsights.com/ask-question/rep-gb-6695

Key Market Segments Covered in Ultrasound systems Market Research

By Modality:

  • Cart/Trolley Based
  • Compact/Hand Held

By Application:

  • Radiology
  • Obstetrics & Gynaecology
  • Cardiology
  • Gastroenterology
  • Others

By End User:

  • Hospitals & Clinics
  • Diagnostic Imaging & Surgical Centers
  • ASCs
  • Others

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries:Ā sales@futuremarketinsights.com
Browse All Reports :Ā https://www.futuremarketinsights.com/reports
LinkedIn|Ā Twitter|Ā Blogs

Heparin-Induced Thrombocytopenia (HIT) Treatment Market Trends, Demand Factors And Outlook 2029

Heparin-Induced Thrombocytopenia (HIT) is an immune-mediated life-threatening complication. It is an adverse drug reaction caused by the generation of antibodies that activates platelet factor 4(PF-4) in the presence of heparin.

Heparin-Induced Thrombocytopenia (HIT) can lead to many thromboembolic complications, such as acute myocardial infarction, pulmonary embolism, deep venous thrombosis, thrombotic stroke and pulmonary embolism.

View Full Report: https://www.futuremarketinsights.com/reports/heparin-induced-thrombocytopenia-hit-treatment-market

A number of laboratory tests like Enzyme-Linked Immunosorbent AssayĀ (ELISA),Ā Serotonin Release Assay (SRA), Enzyme Immunoassay (EIA), Heparin-Induced Platelet Activation (HIPA) Tests are now available to confirm the diagnosis of Heparin-induced thrombocytopenia (HIT) treatment. Heparin-Induced Thrombocytopenia (HIT) treatment can be mediated by three alternativeĀ anticoagulants. These include Lepirudin, Danaparoid and Argatroban.

TheseĀ antithrombotic drugsĀ are immediately active and are direct inhibitors of thrombin. They also inhibit thrombin generation and are routinely monitored. These drugs are monitored with ecarin the clotting time (ECT) for lepirudin, the activated clotting time (ACT) for argatroban, or anti?Xa assays for danaparoid.

However, consideration should be given towards the safety and efficacy of the alternative anticoagulant drug for the heparin-induced thrombocytopenia (HIT) treatment. The patientā€™s clinical status includingĀ renalĀ and hepatic function, likely risks and benefits should be monitored during the heparin-induced thrombocytopenia (HIT) treatment.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/brochure/rep-gb-10978

Heparin-Induced Thrombocytopenia (HIT) Treatment:Ā Drivers and Restraints

Increase administration of various forms of heparin, an anticoagulant for the treatment of cardiovascular and orthopaedic surgery and invasive procedures increase the chances of heparin-induced thrombocytopenia, which drives the heparin-induced thrombocytopenia (HIT) market.

Heparin is widely being used in acute coronary syndromes, atrial fibrillation, venous thromboembolism, dialysis, peripheral occlusive disease, and during extracorporeal circulation which increase the chances of heparin-induced thrombocytopenia (HIT) and drives the market of heparin-induced thrombocytopenia (HIT) treatment.

About 12 million hospitalized patients in the USA, around one third in a year, are receiving heparin, which is expected to drive the heparin-induced thrombocytopenia (HIT) treatment market. However, due to the various complications of heparin-induced thrombocytopenia (HIT) treatment and side effects of the available drugs expected to restraints the heparin-induced thrombocytopenia (HIT) treatment market.

Heparin-Induced Thrombocytopenia (HIT) Treatment:Ā Overview

The growth of heparin-induced thrombocytopenia (HIT) treatment market is expected to be high during forecasting periods due to the life-threatening complication of the disease. Increasing administration of heparin develops the possibilities of life-threatening heparin-induced thrombocytopenia (HIT), which will drive the heparin-induced thrombocytopenia (HIT) treatment market.

However, due to the less availability of sophisticated drugs and therapies, there is a huge opportunity among the key market players for the development of novel drug and therapies for the heparin-induced thrombocytopenia (HIT) treatment during the near forecasting periods

Heparin-Induced Thrombocytopenia (HIT) Treatment Market: Region-wise Outlook

U.S. is expected as the largest regional market share in the heparin-induced thrombocytopenia (HIT) treatment market owing to high patient awareness levels, the presence of more number of market players, increasing awareness about heparin-induced thrombocytopenia (HIT) treatment and marketing activities in the region followed by Europe.

The heparin-induced thrombocytopenia (HIT) treatment market is expected to grow fastest in the Asia Pacific may because of the increasing prevalence of cardiovascular and acute coronary syndromes, thus boosting the market growth.

However, in the South Asian countries such as India and China, the opportunities to manufacture and distribute new heparin-induced thrombocytopenia (HIT) treatment drugs is expected to be higher due to large population and increasing incidence of heparin-induced thrombocytopenia during forecasting periods.

Inquire Before Buying Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-10978

Heparin-Induced Thrombocytopenia (HIT) Treatment Market:Ā Key Market Participants

Key players of heparin-induced thrombocytopenia (HIT) treatment market includes Pfizer Inc., Alleviare Life Sciences Pvt. Ltd., ANDOZ, GlaxoSmithKline Plc., Eagle Pharmaceuticals Inc. Teva Pharmaceutical Industries Ltd., WEST-WARD, INC among others.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (India, China ASEAN, Australia & New Zealand)
  • Japan
  • The Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.

The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Unit No: 1602-006
JumeirahĀ Bay 2
Plot No: JLT-PH2-X2A
JumeirahĀ Lakes Towers
Dubai
United Arab Emirates
For Sales Enquiries:Ā sales@futuremarketinsights.com
For Media Enquiries:Ā press@futuremarketinsights.com
Website:Ā https://www.futuremarketinsights.com
LinkedIn|Ā Twitter|Ā Blogs